Ledger.Open graph →
SEC Form D · filed May 12, 2021

TwinStrand Biosciences, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Michael Pellini · Seattle, WADirectorChad Waite · Somerville, MADirectorJesse Salk · Bellevue, WAExec · Director · PromoterKellie Bickel · Seattle, WAExecSteve Dow · Somerville, MADirectorSoma Somasegar · SEATTLE, WADirectorElena Cant · Seattle, WAExecKaren Dabbs · Seattle, WAExecChad Waite · Seattle, WADirectorJesse Salk · Bellevue, WAExec · Director · PromoterKellie Bickel · Seattle, WAExecMichael Pellini · Seattle, WADirectorSteve Dow · San Francisco, CADirectorSoma Somasegar · SEATTLE, WADirectorElena Cant · Seattle, WAExecKaren Dabbs · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗